INBS (Intelligent Bio Solutions) Cash per Share: $1.32 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

INBS Intelligent Bio Solutions Inc INBS
50 GF Score
Price $2.54
GF Value $2.74
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Intelligent Bio Solutions Cash per Share?

Intelligent Bio Solutions INBS +1.01% 50 Cash per Share is $1.32 as of Jun. 2026. GuruFocus rates INBS with a GF Score™ of 50/100 and a GF Value™ of $2.74 (Fairly Valued). The stock has 3 warning signs investors should review.

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Intelligent Bio Solutions's Cash per Share for the quarter that ended in Jun. 2026 was $1.32.

Intelligent Bio Solutions  (NAS:INBS) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

Intelligent Bio Solutions Cash per Share Related Terms

Intelligent Bio Solutions Cash per Share Historical Data

* Premium members only.

The historical data trend for Intelligent Bio Solutions's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Intelligent Bio Solutions Cash per Share Chart

Intelligent Bio Solutions Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,373.00 80.90 18.22 1.39 2.71

Intelligent Bio Solutions Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.39 1.82 0.60 3.43 1.32
INBS
50GF Score
Intelligent Bio Solutions Inc INBS
Cash per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Intelligent Bio Solutions Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Intelligent Bio Solutions's Cash per Share for the fiscal year that ended in Jun. 2026 is calculated as:

Cash per Share= Cash, Cash Equivalents, Marketable Securities /Shares Outstanding (EOP)
=3.992/1.47
=2.71

Intelligent Bio Solutions's Cash per Share for the quarter that ended in Jun. 2026 is calculated as:

Cash per Share= Cash, Cash Equivalents, Marketable Securities /Shares Outstanding (EOP)
=3.992/3.02
=1.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash per Share →
What does a Cash per Share of $1.32 mean?
Intelligent Bio Solutions (INBS) has a Cash per Share of $1.32 as of Jun. 2026. Cash per share is the per-share value of a company's available cash. View historical data for Intelligent Bio Solutions and its competitors.
Is Intelligent Bio Solutions' Cash per Share too high?
Intelligent Bio Solutions' current Cash per Share is $1.32. Overall, Intelligent Bio Solutions has a GF Score™ of 50/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Intelligent Bio Solutions' Cash per Share compare to RMSL and USAQ?
Intelligent Bio Solutions' Cash per Share of $1.32 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash per Share for a Medical Devices & Instruments company?
A good Cash per Share depends on the Medical Devices & Instruments industry context. However, Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash per Share mean?
A high Cash per Share can signal that a stock is expensive relative to its fundamentals. Cash per share is the per-share value of a company's available cash. View historical data for Intelligent Bio Solutions and its competitors. Intelligent Bio Solutions's current Cash per Share is $1.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Intelligent Bio Solutions stock overvalued right now?
Based on GuruFocus' analysis, Intelligent Bio Solutions (INBS) is currently considered Fairly Valued. The stock's GF Value™ is $2.74, compared to a current price of $2.54 — trading 7.2% below its estimated fair value. The current Cash per Share is $1.32. Intelligent Bio Solutions' overall GF Score™ is 50/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash per Share calculated?
Cash per Share is calculated from a company's financial statements. For Intelligent Bio Solutions (INBS), the current Cash per Share is $1.32 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Intelligent Bio Solutions (INBS) Overvalued in 2026?

Based on GuruFocus' analysis, Intelligent Bio Solutions stock appears to be undervalued. The current stock price of $2.54 is trading 7.2% below its estimated GF Value™ of $2.74. GuruFocus considers Intelligent Bio Solutions to be Fairly Valued.

Key valuation signals for INBS:

  • Cash per Share: $1.32
  • GF Value™: $2.74 vs. price of $2.54 (7.2% below fair value)
  • GF Score™: 50/100 with 3 warning signs

No single metric tells the full story. See the INBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Intelligent Bio Solutions Business Description

Address 135 West, 41ST Street, 5th Floor, New York, NY, USA, 10036
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.
50GF Score

Get the complete analysis for INBS

Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.54
Price
$2.74
GF Value